Seegene and QIAGEN Enter Into a Collaboration to Develop Multiplex Molecular Diagnostic Assays

By: via Benzinga
Seegene Inc. (KOSDAQ: 096530), today announced that it has entered into a worldwide collaboration agreement with QIAGEN N.V. (NASDAQ: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.